business.financialpost.com
Amgen wins U.S. patent battle on arthritis drug Enbrel, thwarting Novartis
A U.S. judge on Friday upheld two patents relating to Amgen Inc’s blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis AG , which is seeking to launch a copycat versi…